CN Stock MarketDetailed Quotes

600267 Zhejiang Hisun Pharmaceutical

Watchlist
  • 7.94
  • +0.31+4.06%
Market Closed Sep 27 15:00 CST
9.59BMarket Cap-155686P/E (TTM)

Zhejiang Hisun Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-13.48%5.24B
-11.00%2.73B
-13.82%10.37B
-0.49%8.7B
5.64%6.06B
2.90%3.06B
-0.82%12.04B
-3.99%8.74B
-4.46%5.74B
-2.96%2.98B
Operating revenue
-13.48%5.24B
-11.00%2.73B
-13.82%10.37B
-0.49%8.7B
5.64%6.06B
2.90%3.06B
-0.82%12.04B
-3.99%8.74B
-4.46%5.74B
-2.96%2.98B
Other operating revenue
-20.06%102.82M
----
-34.32%215.53M
----
21.55%128.62M
----
40.19%328.14M
----
9.49%105.82M
----
Total operating cost
-11.80%4.91B
-7.20%2.58B
-9.96%10.13B
-0.61%8.11B
2.98%5.56B
0.15%2.78B
-2.06%11.26B
-5.36%8.17B
-3.87%5.4B
-2.21%2.77B
Operating cost
-10.23%3.18B
-4.91%1.74B
-11.57%6.19B
-0.96%5.11B
3.18%3.54B
1.33%1.83B
-2.61%7B
-4.77%5.16B
-3.28%3.43B
-2.37%1.81B
Operating tax surcharges
33.08%43.92M
13.23%26.91M
-20.83%84.94M
-17.85%59.77M
-26.59%33M
-21.72%23.77M
-0.49%107.3M
-14.65%72.76M
-11.86%44.96M
25.46%30.36M
Operating expense
-19.14%999.87M
-14.21%470.41M
-1.57%2.37B
4.82%1.8B
10.80%1.24B
2.01%548.32M
-3.68%2.41B
-8.74%1.72B
-8.97%1.12B
-3.85%537.53M
Administration expense
-1.17%434.58M
-4.34%212.74M
-13.64%908.67M
-6.67%683.26M
-9.88%439.72M
-7.93%222.39M
5.62%1.05B
2.94%732.08M
8.77%487.91M
3.13%241.53M
Financial expense
-29.21%72.53M
-32.11%37.95M
-27.05%191.67M
-23.99%148.74M
-26.90%102.46M
-24.90%55.89M
-20.68%262.75M
-26.29%195.69M
-24.59%140.16M
-18.52%74.42M
-Interest expense (Financial expense)
-23.57%87.51M
-17.17%46.82M
-23.92%215.4M
-24.05%166.6M
-26.03%114.5M
-26.69%56.52M
-18.13%283.12M
-18.35%219.37M
-17.26%154.8M
-21.34%77.11M
-Interest Income (Financial expense)
-39.49%-15.03M
-93.27%-9.68M
12.60%-23.17M
9.85%-17.15M
13.67%-10.78M
-39.11%-5.01M
-22.22%-26.51M
-30.61%-19.03M
-18.73%-12.48M
57.70%-3.6M
Research and development
-15.74%177.55M
-8.10%89.18M
-8.57%391.95M
8.72%311.38M
16.13%210.71M
16.52%97.04M
14.99%428.69M
8.30%286.4M
13.01%181.44M
8.03%83.29M
Credit Impairment Loss
33.06%-20.32M
88.80%-2.2M
-346.47%-23.48M
47.00%-22.37M
-131.09%-30.36M
-256.14%-19.64M
175.02%9.53M
-19.37%-42.2M
-3.25%-13.14M
62.12%-5.52M
Asset Impairment Loss
14.05%-72.74M
-81.34%-32.27M
-126.54%-285.52M
-28.15%-83.68M
-176.00%-84.63M
38.68%-17.8M
-15.17%-126.04M
14.91%-65.3M
51.62%-30.66M
-10.83%-29.02M
Other net revenue
320.26%152.08M
1,099.15%124.28M
-51.41%-149.21M
129.20%25.69M
-52.70%36.19M
147.68%10.36M
-275.90%-98.55M
-158.93%-87.98M
2,323.57%76.5M
-648.04%-21.74M
Fair value change income
-171.36%-116.84K
-101.41%-21.81K
100.26%278.29K
103.76%1.4M
114.49%163.74K
148.52%1.55M
-503.96%-107.32M
-3,171.53%-37.21M
-237.44%-1.13M
-57.19%622.5K
Invest income
72.91%170.21M
1,511.26%122.62M
163.53%66.06M
422.42%71.83M
49.45%98.44M
204.44%7.61M
-74.87%25.07M
-114.12%-22.28M
980.88%65.87M
-219.51%-7.29M
-Including: Investment income associates
211.32%19.55M
184.38%13.39M
61.68%-60.37M
26.24%-42.89M
1.10%-17.56M
-97.22%-15.87M
-108.01%-157.55M
-163.05%-58.15M
-1,765.89%-17.76M
-259.27%-8.04M
Asset deal income
324.21%2.68M
-100.05%-7.15K
-2,214.55%-11.49M
-2,840.68%-14.83M
-123.61%-1.2M
497.33%15.28M
97.59%-496.47K
-101.90%-504.44K
-67.43%5.07M
-66.59%2.56M
Other revenue
34.58%72.37M
54.75%36.17M
4.20%104.95M
-7.77%73.34M
6.50%53.77M
38.20%23.37M
-13.76%100.71M
4.85%79.52M
-12.85%50.49M
-42.69%16.91M
Operating profit
-8.31%488.07M
-7.74%272.88M
-86.89%89.44M
24.61%611.66M
29.69%532.29M
62.86%295.76M
-2.51%682.48M
-21.97%490.84M
6.10%410.42M
-22.87%181.61M
Add:Non operating Income
171.68%2.25M
424.68%263.4K
-79.68%1.72M
-80.15%962.83K
-78.53%828.94K
-98.33%50.2K
-59.01%8.47M
-71.31%4.85M
-28.79%3.86M
3,597.54%3M
Less:Non operating expense
-90.00%4.76M
1,436.31%2.56M
2,211.81%174.03M
509.23%49.23M
652.58%47.58M
-78.99%166.33K
-90.17%7.53M
-9.49%8.08M
33.53%6.32M
-65.64%791.76K
Total profit
0.01%485.56M
-8.48%270.59M
-112.13%-82.87M
15.54%563.39M
19.01%485.53M
60.84%295.65M
6.09%683.42M
-23.46%487.61M
5.27%407.96M
-21.19%183.82M
Less:Income tax cost
-26.06%51.53M
-55.21%24.24M
-92.64%14.15M
-29.57%105.19M
-21.33%69.7M
13.10%54.11M
43.90%192.19M
86.79%149.36M
84.92%88.59M
5.36%47.84M
Net profit
4.38%434.03M
1.99%246.35M
SL-97.01M
35.46%458.2M
30.21%415.83M
77.63%241.53M
-3.80%491.23M
-39.28%338.25M
-5.96%319.37M
-27.60%135.97M
Net profit from continuing operation
4.38%434.03M
1.99%246.35M
-119.75%-97.01M
35.46%458.2M
30.21%415.83M
77.63%241.53M
-3.80%491.23M
-39.28%338.25M
-5.96%319.37M
-27.60%135.97M
Less:Minority Profit
-110.36%-1.21M
-123.62%-2.18M
-261.88%-3.84M
123.20%15.82M
3,141.79%11.7M
996.00%9.23M
-90.00%2.37M
-87.70%7.09M
-99.39%360.77K
-98.64%842.46K
Net profit of parent company owners
7.70%435.24M
6.99%248.53M
-119.06%-93.17M
33.58%442.38M
26.69%404.14M
71.91%232.3M
0.40%488.86M
-33.70%331.16M
13.88%319.01M
7.48%135.13M
Earning per share
Basic earning per share
5.71%0.37
10.53%0.21
-119.05%-0.08
39.29%0.39
29.63%0.35
72.73%0.19
-2.33%0.42
-36.79%0.28
6.30%0.27
-9.84%0.11
Diluted earning per share
15.63%0.37
23.53%0.21
-119.05%-0.08
39.29%0.39
23.08%0.32
54.55%0.17
-2.33%0.42
-35.19%0.28
4.00%0.26
-7.56%0.11
Other composite income
-134.21%-1.08M
48.35%-717.31K
-87.62%1.31M
-83.61%2.08M
-50.38%3.17M
-952.74%-1.39M
422.99%10.59M
351.69%12.69M
61.92%6.38M
101.08%162.88K
Other composite income of parent company owners
-134.21%-1.08M
48.35%-717.31K
-87.62%1.31M
-83.61%2.08M
-50.38%3.17M
-952.74%-1.39M
422.99%10.59M
351.69%12.69M
61.92%6.38M
101.08%162.88K
Total composite income
3.33%432.95M
2.29%245.63M
-119.07%-95.7M
31.16%460.28M
28.63%419M
76.40%240.14M
-1.09%501.83M
-36.43%350.94M
-5.18%325.75M
-21.21%136.13M
Total composite income of parent company owners
6.59%434.16M
7.32%247.81M
-118.39%-91.86M
29.26%444.46M
25.18%407.3M
70.68%230.91M
3.28%499.45M
-30.45%343.85M
14.54%325.39M
22.22%135.29M
Total composite income of minority owners
-110.36%-1.21M
-123.62%-2.18M
-261.88%-3.84M
123.20%15.82M
3,141.79%11.7M
996.00%9.23M
-90.00%2.37M
-87.70%7.09M
-99.39%360.77K
-98.64%842.46K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -13.48%5.24B-11.00%2.73B-13.82%10.37B-0.49%8.7B5.64%6.06B2.90%3.06B-0.82%12.04B-3.99%8.74B-4.46%5.74B-2.96%2.98B
Operating revenue -13.48%5.24B-11.00%2.73B-13.82%10.37B-0.49%8.7B5.64%6.06B2.90%3.06B-0.82%12.04B-3.99%8.74B-4.46%5.74B-2.96%2.98B
Other operating revenue -20.06%102.82M-----34.32%215.53M----21.55%128.62M----40.19%328.14M----9.49%105.82M----
Total operating cost -11.80%4.91B-7.20%2.58B-9.96%10.13B-0.61%8.11B2.98%5.56B0.15%2.78B-2.06%11.26B-5.36%8.17B-3.87%5.4B-2.21%2.77B
Operating cost -10.23%3.18B-4.91%1.74B-11.57%6.19B-0.96%5.11B3.18%3.54B1.33%1.83B-2.61%7B-4.77%5.16B-3.28%3.43B-2.37%1.81B
Operating tax surcharges 33.08%43.92M13.23%26.91M-20.83%84.94M-17.85%59.77M-26.59%33M-21.72%23.77M-0.49%107.3M-14.65%72.76M-11.86%44.96M25.46%30.36M
Operating expense -19.14%999.87M-14.21%470.41M-1.57%2.37B4.82%1.8B10.80%1.24B2.01%548.32M-3.68%2.41B-8.74%1.72B-8.97%1.12B-3.85%537.53M
Administration expense -1.17%434.58M-4.34%212.74M-13.64%908.67M-6.67%683.26M-9.88%439.72M-7.93%222.39M5.62%1.05B2.94%732.08M8.77%487.91M3.13%241.53M
Financial expense -29.21%72.53M-32.11%37.95M-27.05%191.67M-23.99%148.74M-26.90%102.46M-24.90%55.89M-20.68%262.75M-26.29%195.69M-24.59%140.16M-18.52%74.42M
-Interest expense (Financial expense) -23.57%87.51M-17.17%46.82M-23.92%215.4M-24.05%166.6M-26.03%114.5M-26.69%56.52M-18.13%283.12M-18.35%219.37M-17.26%154.8M-21.34%77.11M
-Interest Income (Financial expense) -39.49%-15.03M-93.27%-9.68M12.60%-23.17M9.85%-17.15M13.67%-10.78M-39.11%-5.01M-22.22%-26.51M-30.61%-19.03M-18.73%-12.48M57.70%-3.6M
Research and development -15.74%177.55M-8.10%89.18M-8.57%391.95M8.72%311.38M16.13%210.71M16.52%97.04M14.99%428.69M8.30%286.4M13.01%181.44M8.03%83.29M
Credit Impairment Loss 33.06%-20.32M88.80%-2.2M-346.47%-23.48M47.00%-22.37M-131.09%-30.36M-256.14%-19.64M175.02%9.53M-19.37%-42.2M-3.25%-13.14M62.12%-5.52M
Asset Impairment Loss 14.05%-72.74M-81.34%-32.27M-126.54%-285.52M-28.15%-83.68M-176.00%-84.63M38.68%-17.8M-15.17%-126.04M14.91%-65.3M51.62%-30.66M-10.83%-29.02M
Other net revenue 320.26%152.08M1,099.15%124.28M-51.41%-149.21M129.20%25.69M-52.70%36.19M147.68%10.36M-275.90%-98.55M-158.93%-87.98M2,323.57%76.5M-648.04%-21.74M
Fair value change income -171.36%-116.84K-101.41%-21.81K100.26%278.29K103.76%1.4M114.49%163.74K148.52%1.55M-503.96%-107.32M-3,171.53%-37.21M-237.44%-1.13M-57.19%622.5K
Invest income 72.91%170.21M1,511.26%122.62M163.53%66.06M422.42%71.83M49.45%98.44M204.44%7.61M-74.87%25.07M-114.12%-22.28M980.88%65.87M-219.51%-7.29M
-Including: Investment income associates 211.32%19.55M184.38%13.39M61.68%-60.37M26.24%-42.89M1.10%-17.56M-97.22%-15.87M-108.01%-157.55M-163.05%-58.15M-1,765.89%-17.76M-259.27%-8.04M
Asset deal income 324.21%2.68M-100.05%-7.15K-2,214.55%-11.49M-2,840.68%-14.83M-123.61%-1.2M497.33%15.28M97.59%-496.47K-101.90%-504.44K-67.43%5.07M-66.59%2.56M
Other revenue 34.58%72.37M54.75%36.17M4.20%104.95M-7.77%73.34M6.50%53.77M38.20%23.37M-13.76%100.71M4.85%79.52M-12.85%50.49M-42.69%16.91M
Operating profit -8.31%488.07M-7.74%272.88M-86.89%89.44M24.61%611.66M29.69%532.29M62.86%295.76M-2.51%682.48M-21.97%490.84M6.10%410.42M-22.87%181.61M
Add:Non operating Income 171.68%2.25M424.68%263.4K-79.68%1.72M-80.15%962.83K-78.53%828.94K-98.33%50.2K-59.01%8.47M-71.31%4.85M-28.79%3.86M3,597.54%3M
Less:Non operating expense -90.00%4.76M1,436.31%2.56M2,211.81%174.03M509.23%49.23M652.58%47.58M-78.99%166.33K-90.17%7.53M-9.49%8.08M33.53%6.32M-65.64%791.76K
Total profit 0.01%485.56M-8.48%270.59M-112.13%-82.87M15.54%563.39M19.01%485.53M60.84%295.65M6.09%683.42M-23.46%487.61M5.27%407.96M-21.19%183.82M
Less:Income tax cost -26.06%51.53M-55.21%24.24M-92.64%14.15M-29.57%105.19M-21.33%69.7M13.10%54.11M43.90%192.19M86.79%149.36M84.92%88.59M5.36%47.84M
Net profit 4.38%434.03M1.99%246.35MSL-97.01M35.46%458.2M30.21%415.83M77.63%241.53M-3.80%491.23M-39.28%338.25M-5.96%319.37M-27.60%135.97M
Net profit from continuing operation 4.38%434.03M1.99%246.35M-119.75%-97.01M35.46%458.2M30.21%415.83M77.63%241.53M-3.80%491.23M-39.28%338.25M-5.96%319.37M-27.60%135.97M
Less:Minority Profit -110.36%-1.21M-123.62%-2.18M-261.88%-3.84M123.20%15.82M3,141.79%11.7M996.00%9.23M-90.00%2.37M-87.70%7.09M-99.39%360.77K-98.64%842.46K
Net profit of parent company owners 7.70%435.24M6.99%248.53M-119.06%-93.17M33.58%442.38M26.69%404.14M71.91%232.3M0.40%488.86M-33.70%331.16M13.88%319.01M7.48%135.13M
Earning per share
Basic earning per share 5.71%0.3710.53%0.21-119.05%-0.0839.29%0.3929.63%0.3572.73%0.19-2.33%0.42-36.79%0.286.30%0.27-9.84%0.11
Diluted earning per share 15.63%0.3723.53%0.21-119.05%-0.0839.29%0.3923.08%0.3254.55%0.17-2.33%0.42-35.19%0.284.00%0.26-7.56%0.11
Other composite income -134.21%-1.08M48.35%-717.31K-87.62%1.31M-83.61%2.08M-50.38%3.17M-952.74%-1.39M422.99%10.59M351.69%12.69M61.92%6.38M101.08%162.88K
Other composite income of parent company owners -134.21%-1.08M48.35%-717.31K-87.62%1.31M-83.61%2.08M-50.38%3.17M-952.74%-1.39M422.99%10.59M351.69%12.69M61.92%6.38M101.08%162.88K
Total composite income 3.33%432.95M2.29%245.63M-119.07%-95.7M31.16%460.28M28.63%419M76.40%240.14M-1.09%501.83M-36.43%350.94M-5.18%325.75M-21.21%136.13M
Total composite income of parent company owners 6.59%434.16M7.32%247.81M-118.39%-91.86M29.26%444.46M25.18%407.3M70.68%230.91M3.28%499.45M-30.45%343.85M14.54%325.39M22.22%135.29M
Total composite income of minority owners -110.36%-1.21M-123.62%-2.18M-261.88%-3.84M123.20%15.82M3,141.79%11.7M996.00%9.23M-90.00%2.37M-87.70%7.09M-99.39%360.77K-98.64%842.46K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion with explanatory notes------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data